Business Segments · Gain (Loss) on Portfolio Actions
Optum Rx — Gain (Loss) on Portfolio Actions
UnitedHealth Group Optum Rx — Gain (Loss) on Portfolio Actions remained flat by 0.0% to -$375M in Q4 2025 compared to the prior quarter. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementSegment
CategoryCapital Allocation
SignalHigher is better
VolatilityVolatile
First reportedQ1 2025
Last reportedQ4 2025Mar 2, 2026
How to read this metric
A gain indicates successful divestiture of assets at a premium, while a loss suggests impairment or unfavorable terms during portfolio optimization.
Detailed definition
This metric represents the net financial impact resulting from strategic adjustments to the business segment's asset por...
Peer comparison
Similar to 'Net gain/loss on disposal of assets' or 'Non-operating portfolio adjustments' found in other large healthcare services or pharmacy benefit management firms.
Metric ID:
unh_segment_optum_rx_gain_loss_on_portfolio_actionsHistorical Data
1 years
| FY'25 | |
|---|---|
| Value | -$1.5B |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is UnitedHealth Group's optum rx — gain (loss) on portfolio actions?
- UnitedHealth Group (UNH) reported optum rx — gain (loss) on portfolio actions of -$375M in Q4 2025.
- What does optum rx — gain (loss) on portfolio actions mean?
- The net profit or loss generated from selling or restructuring specific assets or business units within the segment.